Acute Systolic Heart Failure Associated with Complement-Mediated Hemolytic Uremic Syndrome

Por Vaughn, John L., Moore, Jared M., Cataland, Spero R.
Publicado no Case Rep Hematol (2015)

ADAMTS13 activity and antigen during therapy and follow-up of patients with idiopathic thrombotic thrombocytopenic purpura: correlation with clinical outcome

Por Yang, Shangbin, Jin, Ming, Lin, Shili, Cataland, Spero, Wu, Haifeng
Publicado em 2011

TTP disease course is independent of myeloma treatment and response

Por Hofmeister, Craig, Jin, Ming, Cataland, Spero R., Benson, Don M., Wu, Haifeng M.
Publicado em 2010

Effect of Prophylactic Cyclosporine Therapy on ADAMTS13 Biomarkers in Patients with Idiopathic Thrombotic Thrombocytopenic Purpura

Por Cataland, Spero R., Jin, Ming, Lin, Shili, Kraut, Eric H, George, James N., Wu, Haifeng M.
Publicado em 2008

Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura

Por Zheng, X. Long, Wu, Haifeng M., Shang, Dezhi, Falls, Erica, Skipwith, Christopher G., Cataland, Spero R., Bennett, Charles L., Kwaan, Hau C.
Publicado em 2010

Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura

Por Cataland, Spero R., Kourlas, Peter J., Yang, Shangbin, Geyer, Susan, Witkoff, Leslie, Wu, Haiwa, Masias, Camila, George, James N., Wu, Haifeng M.
Publicado no Blood Adv (2017)

Venous Thromboembolic Disease: Clinical Practice Guidelines in Oncology

Por Streiff, Michael B., Bockenstedt, Paula L., Cataland, Spero R., Chesney, Carolyn, Eby, Charles, Fanikos, John, Fogarty, Patrick F., Gao, Shuwei, Garcia-Aguilar, Julio, Goldhaber, Samuel Z., Hassoun, Hani, Hendrie, Paul, Holmstrom, Bjorn, Jones, Kimberly A., Kuderer, Nicole, Lee, Jason T., Millenson, Michael M., Neff, Anne T., Ortel, Thomas L., Smith, Judy L., Yee, Gary C., Zakarija, Anaadriana
Publicado em 2011